DPC Dash Valuation
Is X12 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of X12 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: X12 (€9.2) is trading below our estimate of fair value (€15.12)
Significantly Below Fair Value: X12 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for X12?
Key metric: As X12 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is X12's PS Ratio? | |
|---|---|
| PS Ratio | 2.6x |
| Sales | CN¥3.72b |
| Market Cap | CN¥9.60b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.7x |
| Enterprise Value/EBITDA | 35.2x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does X12's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 1.9x | ||
DHER Delivery Hero | 1x | 11.1% | €10.8b |
TIMA ZEAL Network | 6.3x | 14.3% | €955.1m |
MS1 Marley Spoon Group | 0.09x | 10.0% | €15.1m |
TUI1 TUI | 0.2x | 3.8% | €3.8b |
X12 DPC Dash | 2.6x | 24.9% | €10.3b |
Price-To-Sales vs Peers: X12 is expensive based on its Price-To-Sales Ratio (2.6x) compared to the peer average (1.9x).
Price to Sales Ratio vs Industry
How does X12's PS Ratio compare vs other companies in the DE Hospitality Industry?
Price-To-Sales vs Industry: X12 is expensive based on its Price-To-Sales Ratio (2.6x) compared to the European Hospitality industry average (1x).
Price to Sales Ratio vs Fair Ratio
What is X12's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 2.6x |
| Fair PS Ratio | 1.8x |
Price-To-Sales vs Fair Ratio: X12 is expensive based on its Price-To-Sales Ratio (2.6x) compared to the estimated Fair Price-To-Sales Ratio (1.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €9.20 | €9.19 -0.1% | 3.3% | €9.66 | €8.59 | n/a | 8 |
| Nov ’25 | €7.20 | €9.19 +27.6% | 3.3% | €9.66 | €8.59 | n/a | 8 |
| Oct ’25 | €8.70 | €8.91 +2.5% | 3.5% | €9.37 | €8.38 | n/a | 8 |
| Sep ’25 | €7.65 | €8.80 +15.0% | 6.2% | €9.42 | €7.60 | n/a | 8 |
| Aug ’25 | €7.70 | €8.65 +12.3% | 6.5% | €9.45 | €7.62 | n/a | 8 |
| Jul ’25 | €7.35 | €8.56 +16.4% | 5.8% | €9.50 | €7.66 | n/a | 9 |
| Jun ’25 | €6.40 | €8.45 +32.0% | 6.0% | €9.43 | €7.58 | n/a | 8 |
| May ’25 | €6.35 | €8.85 +39.3% | 9.5% | €10.79 | €7.73 | n/a | 9 |
| Apr ’25 | €5.70 | €8.69 +52.5% | 9.4% | €10.65 | €7.59 | n/a | 9 |
| Mar ’25 | €6.70 | €8.75 +30.6% | 9.0% | €10.63 | €7.57 | n/a | 9 |
| Feb ’25 | €6.25 | €8.92 +42.7% | 9.1% | €10.65 | €8.25 | n/a | 6 |
| Jan ’25 | €6.80 | €9.30 +36.8% | 9.4% | €10.77 | €8.46 | n/a | 4 |
| Dec ’24 | €6.95 | €9.14 +31.5% | 9.4% | €10.59 | €8.32 | n/a | 4 |
| Nov ’24 | €7.65 | €9.58 +25.2% | 12.2% | €10.75 | €8.41 | €7.20 | 2 |
Analyst Forecast: Target price is lower than the current share price.